WSCD2

Model summary

A Golgi-associated sulfotransferase that binds sialylated glycans via tandem carbohydrate-recognition modules and transfers sulfate groups onto terminal sialic acid residues of glycolipids and glycoproteins. By installing sulfate esters within the secretory pathway, it contributes to the ordered maturation of heparan sulfate proteoglycans. The enzyme likely resides on the Golgi membrane with a luminal catalytic region that captures glycans and uses a nucleotide-sulfate donor to drive sulfation, functioning within multi-enzyme assemblies that sculpt cell-surface glycomes.

Predicted Gene Ontology terms

1. 01

   I begin with the InterPro architecture.

   The sequence carries IPR051589 (Sialate:O-sulfotransferase family) spanning residues 10–563, which frames the entire catalytic region and assigns the chemistry: transfer of sulfate groups from a nucleotide-sulfate donor to sialylated acceptors. Within this scaffold, two carbohydrate-recognition modules are present: IPR002889 (Carbohydrate-binding WSC domain) appears twice—first at residues 127–219 and then at residues 230–324. Tandem WSC modules typically create a composite lectin surface that binds complex glycans and positions them for catalysis. Downstream, residues 312–548 are annotated as IPR027417 (P-loop containing nucleoside triphosphate hydrolase homologous superfamily). Although this fold often binds NTPs, in Golgi-resident sulfotransferases it is repurposed to stabilize nucleotide-sulfate donors and organize the catalytic pocket rather than to power mechanical work. The ordered layout—N-terminal luminal glycan-binding WSC repeats feeding into a nucleotide-sulfate–handling core embedded in a sialate O-sulfotransferase family—causally dictates sulfotransferase chemistry.

2. 02

   From this architecture, the molecular function resolves into two facets.

   First, the catalytic core and donor/acceptor positioning define GO:0008146 sulfotransferase activity: the enzyme transfers sulfate from a nucleotide-sulfate donor to terminal sialic acid residues of glycoconjugates. Second, the tandem WSC domains and extended luminal surface promote multivalent macromolecular contacts, supporting GO:0005515 protein binding as an intrinsic property necessary for assembling glycan-processing complexes.

3. 03

   The biological process follows directly from the substrate and site of action.

   By installing sulfate esters onto sialylated glycans within the secretory pathway, the enzyme contributes to the maturation of heparan sulfate chains and their attached proteoglycans. This modification step is integral to the ordered assembly line that builds and edits heparan sulfate proteoglycans, aligning with GO:0015012 heparan sulfate proteoglycan biosynthetic process.

4. 04

   Cellular location is implied by both the catalytic system and the domain arrangement.

   Sialate O-sulfotransferases operate in the lumenal face of the Golgi apparatus where glycan modifications occur. The presence of a large luminal catalytic ectodomain and the absence of cytosolic motifs point to a membrane-anchored enzyme functioning at the Golgi membrane, consistent with GO:0000139 Golgi membrane.

5. 05

   Mechanistically, the tandem WSC domains capture and orient terminal sialic acid–containing glycans on glycolipids and glycoproteins.

   The P-loop–like core and the sialate O-sulfotransferase family scaffold coordinate a nucleotide-sulfate donor and stabilize the transition state for sulfate transfer. This arrangement favors selective modification of sialylated acceptors and explains the enzyme’s role in shaping cell-surface glycomes. I hypothesize that the protein assembles into a Golgi-side modification hub with other glycosylation and sulfation enzymes—such as sialyltransferases and other sulfotransferases—to channel substrates efficiently. Likely partners include luminal lectins and glycosyltransferases that hand off glycan substrates, as well as cytosolic nucleotide-sulfate metabolism factors that maintain donor pools, collectively ensuring precise sulfation during proteoglycan biosynthesis.